Icahn School of Medicine at Mount Sinai

 

Icahn School of Medicine at Mount Sinai
L

MDS: Prospects for Individualized Therapy With Targeted Therapies Post-HMA Failure

By Icahn School of Medicine at Mount Sinai FEATURING Lewis Silverman
By Icahn School of Medicine at Mount Sinai FEATURING Lewis Silverman
60 views
June 16, 2024
0 Comments
Login to view comments. Click here to Login
Myeloid Malignancy Workshop
06:03
Icahn School of Medicine at Mount Sinai

Strategies to Overcome Immune Dysregulation in MPNs

Feat. C. Cimen Bozkus
26:23
Icahn School of Medicine at Mount Sinai

Boosting MHC:TCR Interactions in AML

Feat. I. Aifantis
20:26
Icahn School of Medicine at Mount Sinai

Therapeutic Targeting of RNA Splicing Factor Mutant Leukemias

Feat. O. Abdel-Wahab
03:33
Icahn School of Medicine at Mount Sinai

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associ…

Feat. K. Chin
36:18
Icahn School of Medicine at Mount Sinai

Stem Cell Pathways, Aging, and Cancer Evolution in MPN

Feat. C. Jamieson
28:30
Icahn School of Medicine at Mount Sinai

Leveraging Dysregulated Signaling Networks for Therapeutic Benefit i…

Feat. S. Oh
26:45
Icahn School of Medicine at Mount Sinai

Targeting Mutant Calreticulin in MPN

Feat. A. Mullally
18:59
Icahn School of Medicine at Mount Sinai

BMT for MDS: Updates and Tricky Case Discussion

Feat. A. DeZern
27:08
Icahn School of Medicine at Mount Sinai

Emerging Landscape of Treating Anemia in LR-MDS

Feat. R. Komrokji
29:54
Icahn School of Medicine at Mount Sinai

State-of-the-Art Management of Systemic Mastocytosis

Feat. D. DeAngelo
12:06
Icahn School of Medicine at Mount Sinai

MDS: Prospects for Individualized Therapy With Targeted Therapies Po…

Feat. L. Silverman
48:04
Icahn School of Medicine at Mount Sinai

Integrating Targeted Therapies in AML

Feat. H. Kantarjian
34:57
Icahn School of Medicine at Mount Sinai

BPDCN: Current and Future Directions

Feat. N. Pemmaraju